Cancer vaccine - Immunotech LaboratoriesAlternative Names: IPF-based cancer vaccine - Immunotech Laboratories; Irreversible pepsin fraction-based cancer vaccine - Immunnotech Laboratories
Latest Information Update: 11 Feb 2013
At a glance
- Originator Immunotech Laboratories
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Clinical Phase Unknown Cancer
Most Recent Events
- 15 Mar 2016 Biomarkers information updated
- 01 Jan 2013 Clinical trials in Cancer in USA (unspecified route)